The venture is a pre-seed AI/biotech startup, which aligns with the deep-tech focus of the France BPI & i-Lab 2026 grant. The grant's non-repayable funding of up to €600K could support the venture's proof-of-concept validation and further development. The geography requirement of France also matches the venture's priority location of Île-de-France.